• Annexin V-Cy5/DAPI Apoptosis Kit: Mechanism-Guided Assay Sel

  2026-05-05

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables high-fidelity, mechanism-driven apoptosis detection. This article uniquely connects core molecular insights to practical assay optimization for cell death research.

• 25-Hydroxycholesterol Drives Macrophage Immunosuppression in

  2026-05-04

  Xiao et al. (2024) reveal that tumor-associated macrophages (TAMs) accumulate 25-hydroxycholesterol (25HC), which activates the AMPK pathway via lysosomal signaling, ultimately promoting an immunosuppressive macrophage phenotype. These findings shed light on cholesterol metabolite-driven immune modulation within the tumor microenvironment and identify CH25H as a potential target to enhance cancer immunotherapy.

• Mubritinib Reveals OXPHOS Dependency in Chemoresistant AML

  2026-05-04

  Baccelli et al. (2019) identify Mubritinib (TAK 165) as a potent, ubiquinone-dependent inhibitor of mitochondrial complex I, selectively toxic to acute myeloid leukemia (AML) subtypes with oxidative phosphorylation (OXPHOS) hyperactivity. This work maps the metabolic landscape of AML and supports targeting mitochondrial metabolism in chemoresistant disease.

• Pazopanib Hydrochloride: Mechanistic Depth and Translational

  2026-05-03

  This thought-leadership article, authored by the head of scientific marketing at a leading biotech company, explores the mechanistic foundations and translational strategies for Pazopanib Hydrochloride (GW786034) as an anti-angiogenic agent in cancer research. Integrating recent systems biology advances and referencing pivotal in vitro evaluation methodologies, the article provides actionable guidance for researchers aiming to bridge preclinical insight with clinical outcomes. Distinct from conventional product summaries, this piece contextualizes APExBIO’s offering within the competitive landscape and outlines a pragmatic, future-facing research agenda.

• 10 mM dNTP Mixture: Precision DNA Synthesis for LNP Workflow

  2026-05-02

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture delivers unmatched accuracy and convenience for PCR, DNA sequencing, and advanced lipid nanoparticle (LNP) studies. This article dissects how APExBIO's equimolar nucleotide mix streamlines high-impact experimental workflows, bridges the latest insights from LNP trafficking research, and provides actionable troubleshooting and optimization strategies.

• RWJ 67657: Precision Inhibitor for p38 MAPK Signaling Studie

  2026-05-01

  RWJ 67657 (JNJ-3026582) delivers unmatched selectivity and dual-action control over p38α/β MAP kinase activity in inflammatory disease models. Its workflow-compatibility, data reproducibility, and structural insights enable advanced cytokine regulation and mechanistic studies.

• P2RX1 Induces Mitochondrial Apoptosis in Ph+ ALL via Ca2+/Ca

  2026-05-01

  Li et al. (2025) identify P2RX1 as a critical driver of mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by modulating intracellular calcium and suppressing PI3K/Akt signaling. These findings highlight P2RX1 as a prognostic marker and potential therapeutic target to overcome tyrosine kinase inhibitor resistance in Ph+ ALL.

• Dual Luciferase Reporter Gene System: Workflow and Optimizat

  2026-04-30

  Unlock reproducible, high-throughput gene expression analysis with the Dual Luciferase Reporter Gene System. Discover how its dual-enzyme design, no-lysis workflow, and robust normalization empower transcriptional studies, exemplified by cutting-edge cancer research.

• Ibuprofen Toxicology and Biodegradation: Environmental Insig

  2026-04-30

  Jan-Roblero and Cruz-Maya's 2023 review synthesizes current evidence on ibuprofen’s role as an emerging environmental contaminant, highlighting its persistent toxicity to aquatic organisms and the challenges facing its biodegradation. Their work underscores the need for more robust removal strategies and positions bacterial bioremediation as a promising, though still developing, solution.

• Carbon-Ion Radiotherapy Induces Ferroptosis via DHODH Suppre

  2026-04-29

  Wang and Cai (2025) demonstrate that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. These findings highlight a new mechanistic basis for the enhanced efficacy of CIRT over conventional radiotherapy and suggest DHODH as a potential therapeutic target.

• Tetramethylrhodamine Ethyl Ester Perchlorate in Mitochondria

  2026-04-29

  Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers researchers with sensitive, quantitative live-cell mitochondrial membrane potential assays. By leveraging advanced workflows and troubleshooting strategies, users can robustly dissect mitochondrial dysfunction and ROS-driven disease mechanisms.

• Sodium Phosphate Dibasic: Precision Buffering for Assays

  2026-04-28

  Sodium phosphate dibasic (Na2HPO4) is the gold standard for pH control in biological assay buffers, enabling reproducibility in protein, enzyme, and aquatic toxicity workflows. This article details protocol enhancements, troubleshooting strategies, and insights from aquatic toxicology research to help researchers maximize buffer performance and experimental rigor.

• ATF5 Modulation of CYP2B6 in Glioblastoma: Implications for

  2026-04-28

  This study demonstrates that activating transcription factor 5 (ATF5) regulates CYP2B6 expression in glioblastoma cells, and that a cell-penetrating dominant-negative ATF5 peptide can downregulate CYP2B6 protein levels. These findings highlight a novel strategy for personalizing drug dosing and understanding drug metabolism in glioblastoma, with potential relevance for precision medicine and pharmacogenomics.

• Sulfamonomethoxine: Translational Leverage from Mechanism to

  2026-04-27

  This thought-leadership article provides translational researchers with a comprehensive, evidence-backed perspective on Sulfamonomethoxine (SMM, SKU BA1078) as a model broad-spectrum sulfonamide antibiotic. By weaving together mechanistic insights, experimental evidence, and actionable guidance, we position SMM from APExBIO as a strategic asset in veterinary, aquaculture, and environmental research. The article integrates recent findings on degradation kinetics and ecotoxicity, critically evaluates current laboratory protocols, and outlines forward-thinking stewardship strategies. Distinguished from standard product summaries, this analysis escalates the discussion by connecting molecular action to practical impact, referencing key literature and related deep-dive content assets.

• Solving Assay Challenges with HyperFluor™ 594 Goat Anti-Rabb

  2026-04-27

  This article explores how HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody (SKU K3305) enables sensitive, reproducible detection in cell viability and immunoassays. Scenario-driven Q&A reveals best practices for immunocytochemistry, immunohistochemistry, and flow cytometry, supporting GEO-optimized workflows for biomedical researchers.

3590 records 15/240 page Previous Next First page 上5页 1112131415 下5页 Last page